{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:04:50Z","timestamp":1788818690611,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017217","name":"Institute of Chemistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P4-0053"],"award-info":[{"award-number":["P4-0053"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["BI-FR-21-22-PROTEUS-002\/46143VH"],"award-info":[{"award-number":["BI-FR-21-22-PROTEUS-002\/46143VH"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119099","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:08:03Z","timestamp":1770721683000},"page":"119099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel short-acting non-depolarizing muscle relaxants derived from galantamine: Design, synthesis, and pharmacological evaluation"],"prefix":"10.1016","volume":"196","author":[{"given":"Robert","family":"Frange\u017e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Molg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika C.","family":"\u017du\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-0888","authenticated-orcid":false,"given":"Evelyne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-0703","authenticated-orcid":false,"given":"Catherine","family":"Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2026.119099_bib2","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-443-19088-9.00004-4","article-title":"Chapter 4 - Nicotinic acetylcholine receptors in the brain","author":"Barrantes","year":"2025"},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-biochem-030122-033116","article-title":"The nicotinic acetylcholine receptor and its pentameric homologs: toward an allosteric mechanism of signal transduction at the atomic level","volume":"93","author":"Cecchini","year":"2024","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119099_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1152\/physrev.00015.2011","article-title":"End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease","volume":"92","author":"Sine","year":"2012","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease","volume":"15","author":"Lindstrom","year":"1997","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3565(24)35314-5","article-title":"Neuronal nicotinic acetylcholine receptors as novel drug targets","volume":"292","author":"Lloyd","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119099_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1873-3468.12884","article-title":"Nicotinic acetylcholine receptors in neuropathic and inflammatory pain","volume":"592","author":"Hone","year":"2018","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-6997(24)01406-6","article-title":"International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits","volume":"51","author":"Lukas","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0163-7258(95)02002-0","article-title":"The pharmacology of galanthamine and its analogues","volume":"68","author":"Harvey","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/cr040415t","article-title":"Synthesis and pharmacology of galantamine","volume":"106","author":"Marco-Contelles","year":"2006","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2026.119099_bib12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1185\/030079905X61884","article-title":"Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease","volume":"21","author":"Vellas","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.biopha.2026.119099_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-2007-11411","article-title":"Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology","volume":"11","author":"Coyle","year":"2007","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/1359-6446(96)89089-1","article-title":"New approach to drug therapy in Alzheimer's dementia Alfred Maelicke and Edson X. Albuquerque","volume":"1","author":"Maelicke","year":"1996","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biopha.2026.119099_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","article-title":"Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease","volume":"49","author":"Maelicke","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.biopha.2026.119099_bib16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/brainsci14121163","article-title":"Galantamine-memantine combination in the treatment of parkinson's disease dementia","volume":"14","author":"Frost","year":"2024","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119099_bib17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0022-3565(25)38284-4","article-title":"Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons","volume":"265","author":"Pereira","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)08675-4","article-title":"Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands","volume":"49","author":"Schrattenholz","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119099_bib19","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1016\/S0021-9258(17)34075-9","article-title":"Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor alpha-polypeptide","volume":"269","author":"Schr\u00f6der","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1432-1033.1993.tb18187.x","article-title":"Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine","volume":"216","author":"Schrattenholz","year":"1993","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119099_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jmb.2007.03.067","article-title":"Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors","volume":"369","author":"Hansen","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119099_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1385\/JMN:30:1:227","article-title":"The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease","volume":"30","author":"Popa","year":"2006","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119099_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0922-4106(95)00080-1","article-title":"Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells","volume":"290","author":"Storch","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119099_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0960-894X(00)00059-7","article-title":"Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts","volume":"10","author":"Guillou","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2026.119099_bib25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0968-0896(98)00133-3","article-title":"Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series","volume":"6","author":"Mary","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000542-195003000-00010","article-title":"The use of decamethonium bromide for the production of muscular relaxation","volume":"11","author":"Harris","year":"1950","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119099_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00000542-194207000-00006","article-title":"The use of curare in general anaesthesia","volume":"3","author":"Griffith","year":"1942","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2011.06.003","article-title":"In vivo toxic and lethal cardiovascular effects of a synthetic polymeric 1,3-dodecylpyridinium salt in rodents","volume":"255","author":"Grandi\u010d","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119099_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","article-title":"Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution","volume":"463","author":"Greenblatt","year":"1999","journal-title":"FEBS Lett."},{"issue":"47","key":"10.1016\/j.biopha.2026.119099_bib31","doi-asserted-by":"crossref","first-page":"15405","DOI":"10.1021\/ja0466154","article-title":"The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design","volume":"126","author":"Greenblatt","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119099_bib32","series-title":"Basic and Clinical Pharmacology, fifteenth ed","author":"Katzung","year":"2021"},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00000542-200601000-00022","article-title":"Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms","volume":"104","author":"Martyn","year":"2006","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119099_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-199818020-00002","article-title":"Adverse effects of neuromuscular blockers and their antagonists","volume":"18","author":"Naguib","year":"1998","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.biopha.2026.119099_bib35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1476-5381.1990.tb14159.x","article-title":"Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve","volume":"101","author":"Hong","year":"1990","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(80)90378-7","article-title":"Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes","volume":"61","author":"Molg\u00f3","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119099_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1152\/physrev.1994.74.4.899","article-title":"Quantal acetylcholine release at the vertebrate neuromuscular junction","volume":"74","author":"Van der Kloot","year":"1994","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119099_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s0054000040045","article-title":"The cardiovascular effects of atracurium and it's metabolite","volume":"4","author":"Fukushima","year":"1990","journal-title":"J. Anesth."},{"issue":"5","key":"10.1016\/j.biopha.2026.119099_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/clpt.1986.226","article-title":"Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients","volume":"40","author":"Inada","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2026.119099_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/bja\/58.12.1397","article-title":"Effects of tubocurarine on plasma histamine concentration in the rat, Correlation with the release of histamine from isolated mast cells","volume":"58","author":"Kubota","year":"1986","journal-title":"Br. J. Anaesth."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:46:27Z","timestamp":1781880387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"alternative-id":["S0753332226001319"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119099","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel short-acting non-depolarizing muscle relaxants derived from galantamine: Design, synthesis, and pharmacological evaluation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119099"}}